| HDACi | histone deacetylase inhibitor |
| SAHA | suberoylanilide hydroxamic acid |
| VEGFR1/2i | vascular endothelial growth factor-1 and -2 receptor inhibitor |
| TNBC | triple-negative breast cancer |
| EGFR | epidermal growth factor receptor |
| VEGFR | vascular endothelial growth factor receptor |
| PI3K | phosphatidylInositol 3-kinase |
| STAT3 | signal transducer and activator of transcription 3 |
| IC50 | half maximal inhibitory concentration |
| MMP | mitochondrial transmembrane potential |
| ROS | reactive oxygen species |
| AVO | acidic vesicular organelle |
| PDGFR | platelet-derived growth factor receptors |
| BID | BH3 interacting-domain death agonist |
| TRAIL | TNF-related apoptosis-inducing ligand |
| FBS | fetal bovine serum |
| EDTA | ethylenediaminetetraacetic acid |
| SDS-PAGE | sodium dodecyl sulphate-polyacrylamide gel electrophoresis |